The intricate link between glucocorticoids and endocannabinoids at stress-relevant synapses in the hypothalamus

Neuroscience

Volumn 204, Issue , 2012, Pages 31-37

  Crosby, K M ^a   Bains, J S ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Corticosteroids; Dorsomedial hypothalamus; Endocannabinoids; Paraventricular nucleus of the hypothalamus; Stress

Indexed keywords

ENDOCANNABINOID; GLUCOCORTICOID;

ACUTE STRESS; AUTONOMIC NERVOUS SYSTEM; CHRONIC STRESS; DORSOMEDIAL HYPOTHALAMIC NUCLEUS; DOWN REGULATION; HUMAN; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS NUCLEUS; MENTAL STRESS; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STRESS; SYNAPTIC TRANSMISSION;

ANIMALS; ENDOCANNABINOIDS; GLUCOCORTICOIDS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; HYPOTHALAMUS; NEURONS; PITUITARY-ADRENAL SYSTEM; SIGNAL TRANSDUCTION; STRESS, PSYCHOLOGICAL; SYNAPSES;

EID: 84857132397     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.11.049     Document Type: Review

References (67)

1. Bailey T.W., DiMicco J.A. Chemical stimulation of the dorsomedial hypothalamus elevates plasma ACTH in conscious rats. Am J Physiol Regul Integr Comp Physiol 2001, 280:R8-R15.
2. Barna I., Zelena D., Arszovszki A.C., Ledent C. The role of endogenous cannabinoids in the hypothalamo-pituitary-adrenal axis regulation: in vivo and in vitro studies in CB1 receptor knockout mice. Life Sci 2004, 75:2959-2970.
3. Bellinger L.L., Bernardis L.L. The dorsomedial hypothalamic nucleus and its role in ingestive behavior and body weight regulation: lessons learned from lesioning studies. Physiol Behav 2002, 76:431-442.
4. Bellocchio L., Lafenêtre P., Cannich A., Cota D., Puente N., Grandes P., Chaouloff F., Piazza P.V., Marsicano G. Bimodal control of stimulated food intake by the endocannabinoid system. Nat Neurosci 2010, 13:281-283.
5. Bernardis L.L. Participation of the dorsomedial hypothalamic nucleus in the "feeding center" and water intake circuitry of the weanling rat. J Neurovisc. Relat 1970, 31:387-398.
6. Bernardis L.L., Bellinger L.L. The dorsomedial hypothalamic nucleus revisited: 1986 update. Brain Res 1987, 434:321-381.
7. Bernardis L.L., Bellinger L.L. The dorsomedial hypothalamic nucleus revisited: 1998 update. Proc Soc Exp Biol Med 1998, 218:284-306.
8. Bligh M.E., DeStefano M.B., Kramlik S.K., Douglass L.W., Dubuc P., Castonguay T.W. Adrenal modulation of the enhanced fat intake subsequent to fasting. Physiol Behav 1990, 48:373-381.
9. Boudaba C., Schrader L.A., Tasker J.G. Physiological evidence for local excitatory synaptic circuits in the rat hypothalamus. J Neurophysiol 1997, 77:3396-3400.
10. Cota D., Marsicano G., Tschöp M., Grübler Y., Flachskamm C., Schubert M., Auer D., Yassouridis A., Thöne-Reineke C., Ortmann S., Tomassoni F., Cervino C., Nisoli E., Linthorst A.C., Pasquali R., Lutz B., Stalla G.K., Pagotto U. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest 2003, 112:423-431.
11. Cota D., Steiner M.A., Marsicano G., Cervino C., Herman J.P., Grübler Y., Stalla J., Pasquali R., Lutz B., Stalla G.K., Pagotto U. Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function. Endocrinology 2007, 148:1574-1581.
12. Crosby K.M., Inoue W., Pittman Q.J., Bains J.S. Endocannabinoids gate state-dependent plasticity of synaptic inhibition in feeding circuits. Neuron 2011, 71:529-541.
13. Cullinan W.E., Helmreich D.L., Watson S.J. Fos expression in forebrain afferents to the hypothalamic paraventricular nucleus following swim stress. J Comp Neurol 1996, 368:88-99.
14. Day T.A. Defining stress as a prelude to mapping its neurocircuitry: no help from allostasis. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:1195-1200.
15. Di S., Malcher-Lopes R., Halmos K.C., Tasker J.G. Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism. J Neurosci 2003, 23:4850-4857.
16. DiMicco J.A., Abshire V.M. Evidence for GABAergic inhibition of a hypothalamic sympathoexcitatory mechanism in anesthetized rats. Brain Res 1987, 402:1-10.
17. Drolet G., Beaulieu J., Mansi J.A., Champagne D., Laforest S. [Relationship between exposure to stress and development of hypertension]. Ann Endocrinol (Paris) 1995, 56:187-191.
18. Engelmann M., Thrivikraman K.V., Su Y., Nemeroff C.B., Montkowski A., Landgraf R., Holsboer F., Plotsky P.M. Endocrine and behavioral effects of airpuff-startle in rats. Psychoneuroendocrinology 1996, 21:391-400.
19. Evanson N.K., Tasker J.G., Hill M.N., Hillard C.J., Herman J.P. Fast feedback inhibition of the HPA axis by glucocorticoids is mediated by endocannabinoid signaling. Endocrinology 2010, 151:4811-4819.
20. Hashimotodani Y., Ohno-Shosaku T., Kano M. Presynaptic monoacylglycerol lipase activity determines basal endocannabinoid tone and terminates retrograde endocannabinoid signaling in the hippocampus. J Neurosci 2007, 27:1211-1219.
21. Hewitt S.A., Wamsteeker J.I., Kurz E.U., Bains J.S. Altered chloride homeostasis removes synaptic inhibitory constraint of the stress axis. Nat Neurosci 2009, 12:438-443.
22. Hill M.N., Carrier E.J., Ho W.S., Shi L., Patel S., Gorzalka B.B., Hillard C.J. Prolonged glucocorticoid treatment decreases cannabinoid CB1 receptor density in the hippocampus. Hippocampus 2008, 18:221-226.
23. Hill M.N., Hunter R.G., McEwen B.S. Chronic stress differentially regulates cannabinoid CB1 receptor binding in distinct hippocampal subfields. Eur J Pharmacol 2009, 614:66-69.
24. Hill M.N., Karatsoreos I.N., Hillard C.J., McEwen B.S. Rapid elevations in limbic endocannabinoid content by glucocorticoid hormones in vivo. Psychoneuroendocrinology 2010, 35:1333-1338.
25. Hill M.N., McLaughlin R.J., Pan B., Fitzgerald M.L., Roberts C.J., Lee T.T., Karatsoreos I.N., Mackie K., Viau V., Pickel V.M., McEwen B.S., Liu Q.S., Gorzalka B.B., Hillard C.J. Recruitment of prefrontal cortical endocannabinoid signaling by glucocorticoids contributes to termination of the stress response. J Neurosci 2011, 31:10506-10515.
26. Hill M.N., Patel S., Carrier E.J., Rademacher D.J., Ormerod B.K., Hillard C.J., Gorzalka B.B. Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress. Neuropsychopharmacology 2005, 30:508-515.
27. Hoffman A.F., Lupica C.R. Mechanisms of cannabinoid inhibition of GABA(A) synaptic transmission in the hippocampus. J Neurosci 2000, 20:2470-2479.
28. Howlett A.C., Barth F., Bonner T.I., Cabral G., Casellas P., Devane W.A., Felder C.C., Herkenham M., Mackie K., Martin B.R., Mechoulam R., Pertwee R.G. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 2002, 54:161-202.
29. Jahng J.W., Lee J.Y., Yoo S.B., Kim Y.M., Ryu V., Kang D.W., Lee J.H. Refeeding-induced expression of neuronal nitric oxide synthase in the rat paraventricular nucleus. Brain Res 2005, 1048:185-192.
30. Keim S.R., Shekhar A. The effects of GABAA receptor blockade in the dorsomedial hypothalamic nucleus on corticotrophin (ACTH) and corticosterone secretion in male rats. Brain Res 1996, 739:46-51.
31. Keller-Wood M.E., Dallman M.F. Corticosteroid inhibition of ACTH secretion. Endocr Rev 1984, 5:1-24.
32. Kim J., Isokawa M., Ledent C., Alger B.E. Activation of muscarinic acetylcholine receptors enhances the release of endogenous cannabinoids in the hippocampus. J Neurosci 2002, 22:10182-10191.
33. Kreitzer A.C., Regehr W.G. Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron 2001, 29:717-727.
34. Lupien S.J., Nair N.P., Brière S., Maheu F., Tu M.T., Lemay M., McEwen B.S., Meaney M.J. Increased cortisol levels and impaired cognition in human aging: implication for depression and dementia in later life. Rev Neurosci 1999, 10:117-139.
35. Mackie K., Lai Y., Westenbroek R., Mitchell R. Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. J Neurosci 1995, 15:6552-6561.
36. Maejima T., Hashimoto K., Yoshida T., Aiba A., Kano M. Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors. Neuron 2001, 31:463-475.
37. Malcher-Lopes R., Di S., Marcheselli V.S., Weng F.J., Stuart C.T., Bazan N.G., Tasker J.G. Opposing crosstalk between leptin and glucocorticoids rapidly modulates synaptic excitation via endocannabinoid release. J Neurosci 2006, 26:6643-6650.
38. McEwen B.S. Stress, adaptation, and disease. Allostasis and allostatic load. Ann N Y Acad Sci 1998, 840:33-44.
39. McEwen B.S. The neurobiology of stress: from serendipity to clinical relevance. Brain Res 2000, 886:172-189.
40. McEwen B.S. Mood disorders and allostatic load. Biol Psychiatry 2003, 54:200-207.
41. Mihály E., Fekete C., Légrádi G., Lechan R.M. Hypothalamic dorsomedial nucleus neurons innervate thyrotropin-releasing hormone-synthesizing neurons in the paraventricular nucleus. Brain Res 2001, 891:20-31.
42. Morin S.M., Stotz-Potter E.H., DiMicco J.A. Injection of muscimol in dorsomedial hypothalamus and stress-induced Fos expression in paraventricular nucleus. Am J Physiol Regul Integr Comp Physiol 2001, 280:R1276-R1284.
43. Ohno-Shosaku T., Maejima T., Kano M. Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron 2001, 29:729-738.
44. Ohno-Shosaku T., Matsui M., Fukudome Y., Shosaku J., Tsubokawa H., Taketo M.M., Manabe T., Kano M. Postsynaptic M1 and M3 receptors are responsible for the muscarinic enhancement of retrograde endocannabinoid signalling in the hippocampus. Eur J Neurosci 2003, 18:109-116.
45. Pan B., Wang W., Long J.Z., Sun D., Hillard C.J., Cravatt B.F., Liu Q.S. Blockade of 2-arachidonoylglycerol hydrolysis by selective monoacylglycerol lipase inhibitor 4-nitrophenyl 4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) enhances retrograde endocannabinoid signaling. J Pharmacol Exp Ther 2009, 331:591-597.
46. Patel S., Kingsley P.J., Mackie K., Marnett L.J., Winder D.G. Repeated homotypic stress elevates 2-arachidonoylglycerol levels and enhances short-term endocannabinoid signaling at inhibitory synapses in basolateral amygdala. Neuropsychopharmacology 2009, 34:2699-2709.
47. Patel S., Roelke C.T., Rademacher D.J., Cullinan W.E., Hillard C.J. Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis. Endocrinology 2004, 145:5431-5438.
48. Pertwee R.G. Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther 1997, 74:129-180.
49. Rossi S., De Chiara V., Musella A., Kusayanagi H., Mataluni G., Bernardi G., Usiello A., Centonze D. Chronic psychoemotional stress impairs cannabinoid-receptor-mediated control of GABA transmission in the striatum. J Neurosci 2008, 28:7284-7292.
50. Safo P.K., Cravatt B.F., Regehr W.G. Retrograde endocannabinoid signaling in the cerebellar cortex. Cerebellum 2006, 5:134-145.
51. Selye H. A syndrome produced by diverse nocuous agents. 1936. J Neuropsychiatry Clin Neurosci 1998, 10:230-231.
52. Steiner M.A., Marsicano G., Wotjak C.T., Lutz B. Conditional cannabinoid receptor type 1 mutants reveal neuron subpopulation-specific effects on behavioral and neuroendocrine stress responses. Psychoneuroendocrinology 2008, 33:1165-1170.
53. Stotz-Potter E.H., Morin S.M., DiMicco J.A. Effect of microinjection of muscimol into the dorsomedial or paraventricular hypothalamic nucleus on air stress-induced neuroendocrine and cardiovascular changes in rats. Brain Res 1996, 742:219-224.
54. Stotz-Potter E.H., Willis L.R., DiMicco J.A. Muscimol acts in dorsomedial but not paraventricular hypothalamic nucleus to suppress cardiovascular effects of stress. J Neurosci 1996, 16:1173-1179.
55. Straiker A., Mackie K. Depolarization-induced suppression of excitation in murine autaptic hippocampal neurones. J Physiol 2005, 569:501-517.
56. Szabo B., Urbanski M.J., Bisogno T., Di Marzo V., Mendiguren A., Baer W.U., Freiman I. Depolarization-induced retrograde synaptic inhibition in the mouse cerebellar cortex is mediated by 2-arachidonoylglycerol. J Physiol 2006, 577:263-280.
57. Thompson R.H., Canteras N.S., Swanson L.W. Organization of projections from the dorsomedial nucleus of the hypothalamus: a PHA-L study in the rat. J Comp Neurol 1996, 376:143-173.
58. Twitchell W., Brown S., Mackie K. Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons. J Neurophysiol 1997, 78:43-50.
59. Van Sickle M.D., Duncan M., Kingsley P.J., Mouihate A., Urbani P., Mackie K., Stella N., Makriyannis A., Piomelli D., Davison J.S., Marnett L.J., Di Marzo V., Pittman Q.J., Patel K.D., Sharkey K.A. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 2005, 310:329-332.
60. Varma N., Carlson G.C., Ledent C., Alger B.E. Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus. J Neurosci 2001, 21:RC188.
61. Wade M.R., Degroot A., Nomikos G.G. Cannabinoid CB1 receptor antagonism modulates plasma corticosterone in rodents. Eur J Pharmacol 2006, 551:162-167.
62. Wamsteeker J.I., Kuzmiski J.B., Bains J.S. Repeated stress impairs endocannabinoid signaling in the paraventricular nucleus of the hypothalamus. J Neurosci 2010, 30:11188-11196.
63. Wang W., Sun D., Pan B., Roberts C.J., Sun X., Hillard C.J., Liu Q.S. Deficiency in endocannabinoid signaling in the nucleus accumbens induced by chronic unpredictable stress. Neuropsychopharmacology 2010, 35:2249-2261.
64. Watts A.G. Glucocorticoid regulation of peptide genes in neuroendocrine CRH neurons: a complexity beyond negative feedback. Front Neuroendocrinol 2005, 26:109-130.
65. Wilson R.I., Nicoll R.A. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 2001, 410:588-592.
66. Zaretskaia M.V., Zaretsky D.V., Sarkar S., Shekhar A., DiMicco J.A. Induction of Fos-immunoreactivity in the rat brain following disinhibition of the dorsomedial hypothalamus. Brain Res 2008, 1200:39-50.
67. Zhong P., Pan B., Gao X.P., Blankman J.L., Cravatt B.F., Liu Q.S. Genetic deletion of monoacylglycerol lipase alters endocannabinoid-mediated retrograde synaptic depression in the cerebellum. J Physiol 2011, 589:4847-4855.